It's a nice ann from imm. I saw that they had news, but I missed...

It's a nice ann from imm.

I saw that they had news, but I missed it as I only noticed the cap raising ann.

I spotted it later (thanks Kates9999) and bought a million at 2.6c, but sold them at 2.625 - so $200 profit - woo hoo! I realised that I just didn't want to be holding them. But thanks to Kates's heads up that's a few free nights out!

There are so many trials with Keytruda. I just did a search on recruiting and not yet recruiting and it shows 596 (link below).

They have promise, but it's in a very competitive landscape. I had a look at their newsletter, but it seemed stuffy to me, with those profiles of the directors looking like an old boy network.

I'm probably not doing them justice at all, it's just the imu bunch remind me of the old microsoft team. Some mad professors, some geeks, lots of dedicated people and most very smart and forward thinking. But they have the proven track records to boot. I thought their weakest link was PH, and he's just helped vla get taken over.

I guess with imm they are coming up with what might be a better version of the propeller engine, and imu are wind testing their RB211.

https://www.clinicaltrials.gov/ct2/results?term=keytruda&recrs=ab